Abstract
Neutron capture therapy (NCT) appears potentially useful, not only as a treatment modality per se, but also as an adjuvant in the context of established clinical measures to control pathological growth. Since the probability of local control is a steep function of absorbed dose, even a modest specific exposure of neoplasms by such techniques would significantly increase the chances of cure. Such a prospect seems most natural in fast neutron therapy 1,2,3 where slow neutrons are automatically available in the target area. As a promising alternative, it would be possible to combine the use of protons or heavier ions with a booster therapy based on boron compounds and intermediate-energy neutrons.4 Such a situation would be particularly relevant when there are needs both for the precision of heavy charged-particle beams--permitting tailored 3-dimensional dose plans for the treatment of structures visible by computerized imaging methods--and for the particular features of NCT that also aim at eradication of invisible but suspected microsopic growth in larger anatomical regions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.